Barras and coworkers from a cohort of 218 BRAFV600E mutant CRC identified two subtypes of disease with different prognosis: BM1 (BRAF mutant 1) and BM2 (BRAF mutant 2) [79]. Here, BRAF is linked to colorectal carcinoma.